290 related articles for article (PubMed ID: 15198385)
1. Cytokines, matrix metalloproteinases and tissue inhibitor of metalloproteinases-1 in gingival crevicular fluid from patients with Papillon-Lefèvre syndrome.
Ullbro C; Crossner CG; Nederfors T; Parhar R; Al Mohanna F; Meikle MC; Reynolds JJ; Twetman S
Acta Odontol Scand; 2004 Apr; 62(2):70-4. PubMed ID: 15198385
[TBL] [Abstract][Full Text] [Related]
2. Altered relationship between MMP-8 and TIMP-2 in gingival crevicular fluid in adolescents with Down's syndrome.
Tsilingaridis G; Yucel-Lindberg T; Modéer T
J Periodontal Res; 2013 Oct; 48(5):553-62. PubMed ID: 23298307
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases and myeloperoxidase in gingival crevicular fluid provide site-specific diagnostic value for chronic periodontitis.
Leppilahti JM; Hernández-Ríos PA; Gamonal JA; Tervahartiala T; Brignardello-Petersen R; Mantyla P; Sorsa T; Hernández M
J Clin Periodontol; 2014 Apr; 41(4):348-56. PubMed ID: 24382144
[TBL] [Abstract][Full Text] [Related]
4. Collagenolytic fragments and active gelatinase complexes in periodontitis.
Bildt MM; Bloemen M; Kuijpers-Jagtman AM; Von den Hoff JW
J Periodontol; 2008 Sep; 79(9):1704-11. PubMed ID: 18771372
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in gingival crevicular fluid during orthodontic tooth movement.
Bildt MM; Bloemen M; Kuijpers-Jagtman AM; Von den Hoff JW
Eur J Orthod; 2009 Oct; 31(5):529-35. PubMed ID: 19299245
[TBL] [Abstract][Full Text] [Related]
6. Host-derived biomarkers at teeth and implants in partially edentulous patients. A 10-year retrospective study.
Ramseier CA; Eick S; Brönnimann C; Buser D; Brägger U; Salvi GE
Clin Oral Implants Res; 2016 Feb; 27(2):211-7. PubMed ID: 25682848
[TBL] [Abstract][Full Text] [Related]
7. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
[TBL] [Abstract][Full Text] [Related]
8. Cytokine (interleukin-1beta) and MMP levels in gingival crevicular fluid after use of platelet-rich fibrin or connective tissue graft in the treatment of localized gingival recessions.
Eren G; Tervahartiala T; Sorsa T; Atilla G
J Periodontal Res; 2016 Aug; 51(4):481-8. PubMed ID: 26447636
[TBL] [Abstract][Full Text] [Related]
9. Effects of phase I periodontal treatment on gingival crevicular fluid levels of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2002 May; 73(5):487-93. PubMed ID: 12027249
[TBL] [Abstract][Full Text] [Related]
10. The associations between gingival crevice fluid matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and periodontitis in human immunodeficiency virus-positive patients.
Alpagot T; Suzara V; Bhattacharyya M
J Periodontal Res; 2006 Dec; 41(6):491-7. PubMed ID: 17076772
[TBL] [Abstract][Full Text] [Related]
11. Gingival crevicular fluid matrix metalloproteinase (MMP)-7, extracellular MMP inducer, and tissue inhibitor of MMP-1 levels in periodontal disease.
Emingil G; Tervahartiala T; Mãntylã P; Määttä M; Sorsa T; Atilla G
J Periodontol; 2006 Dec; 77(12):2040-50. PubMed ID: 17209789
[TBL] [Abstract][Full Text] [Related]
12. Periodontal treatment reduces matrix metalloproteinase levels in localized aggressive periodontitis.
Gonçalves PF; Huang H; McAninley S; Alfant B; Harrison P; Aukhil I; Walker C; Shaddox LM
J Periodontol; 2013 Dec; 84(12):1801-8. PubMed ID: 23537121
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of gingival crevicular fluid levels of tissue plasminogen activator, plasminogen activator inhibitor 2, matrix metalloproteinase-3 and interleukin 1-β in patients with different periodontal diseases.
Toyman U; Tüter G; Kurtiş B; Kıvrak E; Bozkurt Ş; Yücel AA; Serdar M
J Periodontal Res; 2015 Feb; 50(1):44-51. PubMed ID: 24690077
[TBL] [Abstract][Full Text] [Related]
14. Crevicular fluid matrix metalloproteinase-8, -13, and TIMP-1 levels in type 2 diabetics.
Kardeşler L; Biyikoğlu B; Cetinkalp S; Pitkala M; Sorsa T; Buduneli N
Oral Dis; 2010 Jul; 16(5):476-81. PubMed ID: 20233316
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal evaluation of GCF MMP-3 and TIMP-1 levels as prognostic factors for progression of periodontitis.
Alpagot T; Bell C; Lundergan W; Chambers DW; Rudin R
J Clin Periodontol; 2001 Apr; 28(4):353-9. PubMed ID: 11314892
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients.
Ingman T; Tervahartiala T; Ding Y; Tschesche H; Haerian A; Kinane DF; Konttinen YT; Sorsa T
J Clin Periodontol; 1996 Dec; 23(12):1127-32. PubMed ID: 8997658
[TBL] [Abstract][Full Text] [Related]
17. Biomarkers of periodontitis in oral fluids.
Rai B; Kharb S; Jain R; Anand SC
J Oral Sci; 2008 Mar; 50(1):53-6. PubMed ID: 18403884
[TBL] [Abstract][Full Text] [Related]
18. MMP-1, MMP-9, and TIMP-1 levels in oral lichen planus patients with gingivitis or periodontitis.
Ertugrul AS; Dursun R; Dundar N; Avunduk MC; Hakki SS
Arch Oral Biol; 2013 Jul; 58(7):843-52. PubMed ID: 23433942
[TBL] [Abstract][Full Text] [Related]
19. Cathepsin C, matrix metalloproteinases, and their tissue inhibitors in gingiva and gingival crevicular fluid from periodontitis-affected patients.
Soell M; Elkaim R; Tenenbaum H
J Dent Res; 2002 Mar; 81(3):174-8. PubMed ID: 11876270
[TBL] [Abstract][Full Text] [Related]
20. Effects of sub-antimicrobial dose doxycycline therapy on crevicular fluid MMP-8, and gingival tissue MMP-9, TIMP-1 and IL-6 levels in chronic periodontitis.
Choi DH; Moon IS; Choi BK; Paik JW; Kim YS; Choi SH; Kim CK
J Periodontal Res; 2004 Feb; 39(1):20-6. PubMed ID: 14687223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
